NDC 13985-222 - Lidocaine 2%
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-222
- Package NDCs from labels
- 13985-222-04, 13985-222-05
- Manufacturer
- MWI/VetOne
- Effective date
- 2020-02-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine 2% - MWI/VetOne | MWI/VetOne | 2020-02-14 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-222-04 | Lidocaine2% | 100 mL in 1 BOTTLE | INJECTION | 100 | 4 | |
| 13985-222-05 | Lidocaine2% | 250 mL in 1 BOTTLE | INJECTION | 250 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | LIDOCAINE 2% (LIDOCAINE) INJECTION [MWI/VETONE] | 2 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | LIDOCAINE 2% (LIDOCAINE) INJECTION [MWI/VETONE] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | International Medication Systems, Limited | 5d3e9984-cef9-46f2-a6c9-3be8b26f45b3 | 2022-12-29 | Warnings, Adverse reactions | V13007Z41A |
| Bactine Max Dry | LIDOCAINE HYDROCHLORIDE | WellSpring Pharmaceutical Corporation | 466404cd-c46a-4944-b1ac-3b3b17f436a1 | 2022-12-27 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | fecd1797-7757-4da8-b3a1-24b258634243 | 2022-10-12 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 8ae0656c-36fb-48fb-886b-1031d11da552 | 2022-10-12 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | deec52c7-ebcf-422e-beab-bc1df2fe30cb | 2022-10-12 | Warnings, Adverse reactions | V13007Z41A |
| Lidotran | LIDOCAINE HYDROCHLORIDE | PureTek Corporation | cf715e54-c413-1e8f-e053-2995a90a076d | 2022-09-19 | Warnings, Adverse reactions | V13007Z41A |
| Lidothol | LIDOCAINE HCL, MENTHOL | Asclemed USA, Inc. | 6d7adaca-67dd-4a4b-a85c-d1c2a568dee2 | 2022-09-09 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Novitium Pharma LLC | ffb2d794-2c88-48a2-beff-d01b6fcea51f | 2022-03-25 | Warnings, Adverse reactions | V13007Z41A |
| Lydexa 4.12% | LIDOCAINE HYDROCHLORIDE | PureTek Corporation | aa1c9d39-1283-8c6b-e053-2a95a90af5b5 | 2022-03-02 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | International Medication Systems, Limited | 2c48cfac-81eb-4a81-8590-bc94574dd4c3 | 2021-12-14 | Warnings, Adverse reactions | V13007Z41A |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | ba082c2f-64f4-419d-9c88-74f203316e17 | 2021-08-25 | Warnings, Adverse reactions | 1010671 |
| Bactine Max | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | WellSpring Pharmaceutical Corporation | 28e8a311-20a4-45a1-8d5d-ca42b101c275 | 2021-02-24 | Warnings | V13007Z41A |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | 6702589d-6a15-40fe-877a-a9a1a4ad0f7a | 2020-11-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Proficient Rx LP | 5b4b36dd-da60-47de-a2c1-517a52ab3549 | 2020-05-01 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | b8803e38-fe30-48ec-9399-013f2880e0eb | 2020-04-09 | Warnings, Adverse reactions | V13007Z41A |
| DermacinRx Lidotral | LIDOCAINE HYDROCHLORIDE | PureTek Corporation | 23efec58-67cc-418d-85f5-7ef156443cbf | 2019-02-04 | Warnings, Adverse reactions | V13007Z41A |
| Eha | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 09835640-55c3-4bfa-9ad3-15d37f06e871 | 2018-11-01 | Warnings | V13007Z41A |
| SunBurnt PLUS Pain Relief | LIDOCAINE HYDROCHLORIDE | Welmedix LLC dba Welmedix Consumer Healthcare | 6363c695-f801-407d-a4e1-b0d9cfa0a273 | 2018-03-13 | Warnings | V13007Z41A |
| Unburn | LIDOCAINE HYDROCHLORIDE | Water-Jel Technologies | 0c504ba8-8a40-43dd-8c68-62ed106b32a2 | 2017-12-01 | Warnings | V13007Z41A |
| Unburn | LIDOCAINE HYDROCHLORIDE | Water-Jel Technologies | 40164231-1556-4714-9e27-9d41e3c71447 | 2017-11-30 | Warnings | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.